 | The 131st Annual Meeting (November 15-19, 2003) of APHA |
|
| The 131st Annual Meeting (November 15-19, 2003) of APHA |
Christine Rohr, DO, Department of Medical Education and Senior Services, Synergy Medical Education Alliance, 1000 Houghton Ave, Saginaw, MI 48602, Arup P. Sarkar, MD, Department of Family Medicine, Synergy Medical Education Alliance, 1000 Houghton Ave, Saginaw, MI 48602, and John M. Clements, MPA, Department of Research and Educational Programs, Synergy Medical Education Alliance, 1000 Houghton Ave., Saginaw, MI 48602, 989-583-6960, jclements@synergymedical.org.
Objectives: Determine use of treatment and prevention therapies by patients after receiving results of osteoporosis screening. Methods: Phone based survey to follow up with patients who presented for DEXA scans at a community-wide osteoporosis screening project. Results: We were able to determine bone density status and follow-up information for 219 individuals. There were significant increases in use of calcium supplementation among women with normal bone mineral density. At screening 37.0% of women with normal bone mineralization were using calcium supplementation, while at follow-up 61.6% were using calcium supplementation (p = 0.002). Among women with low bone mineral density, the use of HRT decreased (from 21.1% on HRT at screening to 6.3% on HRT at follow-up, a significant decrease, p = 0.003). This group also saw a significant increase in the use of calcium supplementation. Both groups reported increases in the amount of exercise and their dairy intake; however, the differences in the increases between the groups were not statistically significant. Conclusions: Our results indicate that the use of calcium supplementation, not requiring a physician prescription, increases after osteoporosis screening. However, use of other therapies requiring a physician prescription did not increase after screening regardless of the patient's bone mineral density status.
Learning Objectives:
Keywords: Elderly, Prevention
Presenting author's disclosure statement:
I do not have any significant financial interest/arrangement or affiliation with any organization/institution whose products or services are being discussed in this session.